Molecular Templates (MTEM) Investor Presentation - Slideshow

MOLECULAR TEMPLATES Corporate Presentation I September 2020 (NASDAQ: MTEM) Forward-Looking Statements Except for statements of historical fact, the statements in this presentation are forward-looking statements, including statements regarding the future development of our proprietary Engineered Toxin Body (ETB) technology; the future development of evofosfamide; our milestones; our plans to enter the clinic with multiple candidates; our expected receipt of clinical data; and our future cash needs. These sta ...